(Total Views: 323)
Posted On: 12/15/2020 1:25:47 PM
Post# of 24

$RFL News Article - Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613 (devimistat) for the Treatment of Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/rafa...17040.html
My Twitter: WhyteStocks